These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3051160)

  • 21. Neurological disorders of purine and pyrimidine metabolism.
    Micheli V; Camici M; Tozzi MG; Ipata PL; Sestini S; Bertelli M; Pompucci G
    Curr Top Med Chem; 2011; 11(8):923-47. PubMed ID: 21401501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uric acid metabolism in man.
    Balis ME
    Adv Clin Chem; 1976; 18():213-46. PubMed ID: 176879
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined immunodeficiency disease: an inborn error of purine metabolism.
    Pollara B; Moore JJ; Pickering RJ; Gabrielsen AE; Meuwissen HJ
    Birth Defects Orig Artic Ser; 1975; 11(1):120-3. PubMed ID: 1148376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purine excretion by cultured skin fibroblasts from patients with abnormal purine metabolism.
    Holland MJ; Klein NC; Cox RP; Dancis J
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):331-42. PubMed ID: 940964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of purine and pyrimidine metabolites in HPRT-deficient cell lines.
    Yamaoka N; Inazawa K; Inagawa S; Yasuda M; Mawatari K; Nakagomi K; Fujimori S; Yamada Y; Kaneko K
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1256-9. PubMed ID: 22132983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow gene therapy for adenosine deaminase deficiency.
    Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
    Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inherited purine enzyme deficiencies: prenatal diagnosis and heterozygote detection.
    de Bruyn CH
    Clin Biochem; 1983 Feb; 16(1):38-42. PubMed ID: 6407779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-dimensional thin-layer chromatography for the screening of disorders of purine and pyrimidine metabolism.
    van Gennip AH; van Noordenburg-Huistra DY; de Bree PK; Wadman SK
    Clin Chim Acta; 1978 May; 86(1):7-20. PubMed ID: 95907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immune insufficiency in enzyme defects of purine metabolism].
    Müller G
    Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inherited disorders of uric acid metabolism--classification, enzymatic- and DNA-diagnosis].
    Iwahana H; Itakura M
    Nihon Rinsho; 1996 Dec; 54(12):3303-8. PubMed ID: 8976110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enzymopathies as a cause of hyperuricemia].
    Eyman E; Kawenoki-Minc E
    Reumatologia; 1977; 15(3):375-81. PubMed ID: 929012
    [No Abstract]   [Full Text] [Related]  

  • 33. Inborn errors of purine catabolism.
    Van den Berghe G; Everaerts MC; Corbeel L
    Acta Paediatr Belg; 1981; 34(1):3-12. PubMed ID: 6267874
    [No Abstract]   [Full Text] [Related]  

  • 34. Lesch-Nyhan syndrome, caffeine model: increase of purine and pyrimidine enzymes in rat brain.
    Miñana MD; Portolés M; Jordá A; Grisolía S
    J Neurochem; 1984 Dec; 43(6):1556-60. PubMed ID: 6149265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inborn errors of purine metabolism: clinical update and therapies.
    Balasubramaniam S; Duley JA; Christodoulou J
    J Inherit Metab Dis; 2014 Sep; 37(5):669-86. PubMed ID: 24972650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defects of purine metabolism in immunodeficiency diseases.
    Hirschhorn R
    Prog Clin Immunol; 1977; 3():67-83. PubMed ID: 405713
    [No Abstract]   [Full Text] [Related]  

  • 37. Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients.
    Markert ML; Hershfield MS; Schiff RI; Buckley RH
    J Clin Immunol; 1987 Sep; 7(5):389-99. PubMed ID: 3116034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Grunebaum E; Cohen A; Roifman CM
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):630-8. PubMed ID: 24113229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disorders of purines and pyrimidines.
    Kelley RE; Andersson HC
    Handb Clin Neurol; 2014; 120():827-38. PubMed ID: 24365355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Purine metabolic defects in primary immunodeficiency].
    Zhao ML
    Zhonghua Yi Xue Za Zhi; 1982 Jul; 62(7):436-8. PubMed ID: 6293668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.